Zacks Research Cuts Earnings Estimates for Teladoc Health

Teladoc Health, Inc. (NYSE:TDOC) – Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Teladoc Health in a research report issued on Wednesday, March 12th. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings per share of ($0.40) for the quarter, down from their prior forecast of ($0.38). The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share. Zacks Research also issued estimates for Teladoc Health’s Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at ($1.08) EPS, Q2 2026 earnings at ($0.21) EPS, Q4 2026 earnings at ($0.11) EPS and FY2026 earnings at ($0.90) EPS.

A number of other research firms have also recently commented on TDOC. The Goldman Sachs Group dropped their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Bank of America lifted their price target on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Royal Bank of Canada lifted their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Piper Sandler dropped their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research note on Thursday, February 27th. Finally, Oppenheimer dropped their price target on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $11.26.

Teladoc Health Price Performance

TDOC stock opened at $8.40 on Monday. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $15.68. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $10.51 and a 200 day moving average price of $9.74. The stock has a market cap of $1.46 billion, a PE ratio of -1.46 and a beta of 1.27.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million during the quarter, compared to analysts’ expectations of $639.44 million.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently modified their holdings of TDOC. Versant Capital Management Inc raised its holdings in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares in the last quarter. Whipplewood Advisors LLC bought a new stake in shares of Teladoc Health in the 4th quarter valued at about $29,000. Lindbrook Capital LLC raised its holdings in shares of Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Sterling Capital Management LLC raised its holdings in shares of Teladoc Health by 776.7% in the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after purchasing an additional 4,101 shares in the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new stake in shares of Teladoc Health in the 4th quarter valued at about $60,000. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.